Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; Gradowska, Patrycja; Biemond, Bart J; Spertini, Olivier; Vellenga, Edo; Griskevicius, Laimonas; Tick, Lidwine W; Jongen-Lavrencic, Mojca; van Marwijk Kooy, Marinus; Vekemans, Marie-Christiane; van der Velden, Walter J F M; Beverloo, Berna; Michaux, Lucienne; Graux, Carlos; Deeren, Dries; de Weerdt, Okke; van Esser, Joost W J; Bargetzi, Mario; Klein, Saskia K; Gadisseur, Alain; Westerweel, Peter E; Veelken, Hendrik; Gregor, Michael; Silzle, Tobias; van Lammeren-Venema, Daniëlle; Moors, Ine; Breems, Dimitri A; Hoogendoorn, Mels; Legdeur, Marie-Cecile J C; Fischer, Thomas; Kuball, Juergen; Cornelissen, Jan; Porkka, Kimmo; Juliusson, Gunnar; Meyer, Peter; Höglund, Martin; Gjertsen, Bjorn T; Janssen, Jeroen J W M; Huls, Gerwin; Passweg, Jakob; Cloos, Jacqueline; Valk, Peter J M; van Elssen, Catharina H M J; Manz, Markus G; Floisand, Yngvar; Ossenkoppele, Gert J
(The American Society of Hematology, 2021-02-23)
Lenalidomide, an antineoplastic and immunomodulatory drug, has therapeutic activity in acute myeloid leukemia (AML), but definitive studies about its therapeutic utility have been lacking. In a phase 3 study, we compared ...